Join our community of smart investors

Alliance delivers the right medicine

The pharma group is busy integrating its latest acquistion and focusing on its 'international star' portfolio
Alliance delivers the right medicine

Adjusted pre-tax profits of £28.1m at Alliance Pharma (APH) were bang in line with broker Investec’s forecast, as well as numbers already disclosed in a January pre-close trading update. That left little room for surprises on results day, particularly as the ‘international star’ product portfolio continues to perform well. Products in this portfolio have “a distinct USP”, says chief executive Peter Butterfield, as well as high margins, a range of international rights and future growth potential.  

IC TIP: Hold at 66p

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in